In the present study, we found that aberrant expression of BDNF was significantly associated with patient prognosis in several types of cancer, with a particularly remarkable association of high BDNF expression with poor prognosis and aggressive clinicopathological characteristics of PAAD patients. This evidence concerns the gene BDNF and pancreatic adenocarcinoma.